The majority of patients had either TNM stage II or III disease (79%), moderate/well differentiated adenocarcinomas (91%, 18 of which had mucin lakes), venous invasion (57%), an R0 resection (89%), no peritoneal involvement (91%) and no tumour perforation (99%). The gene discussed is MUC5AC; the disease is adenocarcinoma.